HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$4.95
Day range
$4.63 - $4.93
Year range
$3.79 - $14.60
Market cap
220.59M USD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -8.36M | 34.59% |
Net income | -14.07M | -26.84% |
Net profit margin | — | — |
Earnings per share | -0.23 | — |
EBITDA | -7.16M | 26.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 102.65M | 189.88% |
Total assets | 106.87M | 159.38% |
Total liabilities | 40.54M | 42.46% |
Total equity | 66.33M | — |
Shares outstanding | 47.24M | — |
Price to book | 3.49 | — |
Return on assets | -28.82% | — |
Return on capital | -45.93% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -14.07M | -26.84% |
Cash from operations | -5.81M | 21.67% |
Cash from investing | -3.00K | 88.89% |
Cash from financing | 91.91M | 76,061.16% |
Net change in cash | 86.10M | 1,237.33% |
Free cash flow | 19.25M | 632.69% |
About
Founded
2003
Headquarters
Website
Employees
38
